Bank of New York Mellon’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
Other funds holding LFMD
PGCM
BRF
RA
Bank of New York Mellon's LFMD Position: Q2 2026 in Review
Bank of New York Mellon increased its LifeMD (LFMD) stake by 2.3% in Q2 2026, buying an estimated $24.9K and bringing the position to 246,586 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3345.
Bank of New York Mellon first reported a position in LFMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.48M in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.
- Bank of New York Mellon held 246,586 shares of LifeMD worth $1.02M as of Q2 2026.
- Bank of New York Mellon bought 5,651 LifeMD shares in Q2 2026, an estimated $24.9K.
- LifeMD made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3345 holding.
- Bank of New York Mellon first reported a position in LifeMD in Q3 2022 and has held it in 16 quarters since.
- Bank of New York Mellon's LifeMD position peaked at $3.48M in Q2 2025.
- 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.